Phase Forward Reaches 3,000 InForm(TM) Trials Milestone

WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its InForm™ electronic data capture (EDC) solution has been utilized in more than 3,000 live or completed clinical trials to date with end users in 112 countries across the globe. Widely adopted by companies of all sizes across multiple industry segments and clinical trial phases, the InForm solution has led the way for the industry’s embrace of EDC technology to help bring therapies to market more efficiently and cost-effectively.
MORE ON THIS TOPIC